208 related articles for article (PubMed ID: 26730971)
1. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.
Kreicher KL; Kurlander DE; Gittleman HR; Barnholtz-Sloan JS; Bordeaux JS
Dermatol Surg; 2016 Jan; 42 Suppl 1():S24-31. PubMed ID: 26730971
[TBL] [Abstract][Full Text] [Related]
2. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.
Criscione VD; Weinstock MA
J Am Acad Dermatol; 2007 Jun; 56(6):968-73. PubMed ID: 17141362
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.
Kuzel P; Metelitsa AI; Dover DC; Salopek TG
Dermatol Surg; 2012 Sep; 38(9):1461-8. PubMed ID: 22691126
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Outcomes of Dermatofibrosarcoma Protuberans in the US Pediatric Population.
Rubio GA; Alvarado A; Gerth DJ; Tashiro J; Thaller SR
J Craniofac Surg; 2017 Jan; 28(1):182-184. PubMed ID: 27922973
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors, Treatment, and Survival in Dermatofibrosarcoma Protuberans.
Criscito MC; Martires KJ; Stein JA
JAMA Dermatol; 2016 Dec; 152(12):1365-1371. PubMed ID: 27262160
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Survival Outcomes of Dermatofibrosarcoma Protuberans From 2000 to 2020: A Population-Based Retrospective Cohort Analysis.
Xiong DD; Bordeaux JS
Dermatol Surg; 2023 Dec; 49(12):1096-1103. PubMed ID: 37962980
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
Rouhani P; Fletcher CD; Devesa SS; Toro JR
Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
[TBL] [Abstract][Full Text] [Related]
10. Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis.
Trofymenko O; Bordeaux JS; Zeitouni NC
J Am Acad Dermatol; 2018 Jun; 78(6):1125-1134. PubMed ID: 29175214
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological trends and survival outcomes for dermatofibrosarcoma protuberans of the head and neck region.
Go CC; Lahaie Luna GM; Briceño CA
Int J Dermatol; 2023 May; 62(5):664-671. PubMed ID: 36318642
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of a Modern Cohort of Dermatofibrosarcoma Protuberans From 2000 to 2018.
Baig IT; Lauck K; Nguyen QD
J Cutan Med Surg; 2023; 27(2):108-116. PubMed ID: 36655601
[TBL] [Abstract][Full Text] [Related]
14. Elevated risk of subsequent primary malignancies in patients with dermatofibrosarcoma protuberans: An updated retrospective cohort analysis of the Surveillance, Epidemiology, and End Results (SEER) Program.
Joshi TP; Shimizu I
J Am Acad Dermatol; 2024 Jun; 90(6):e199-e200. PubMed ID: 38307143
[No Abstract] [Full Text] [Related]
15. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population.
Mbonde MP; Amir H; Kitinya JN
East Afr Med J; 1996 Jun; 73(6):410-3. PubMed ID: 8840606
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study.
Blake PW; Bradford PT; Devesa SS; Toro JR
Arch Dermatol; 2010 Jun; 146(6):625-32. PubMed ID: 20566926
[TBL] [Abstract][Full Text] [Related]
17. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
18. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
19. Incidence and cost of dermatofibrosarcoma protuberans in mainland urban China: a nationwide retrospective study 2014-2016.
Feng J; Sun Y; Xu L; Liu L; Yang X; Liu G; Wang J; Gao P; Zhao Z; Zhan S; Wang S
Eur J Dermatol; 2023 Jun; 33(3):260-264. PubMed ID: 37594333
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans of the vulva. A case report.
Karlen JR; Johnson K; Kashkari S
J Reprod Med; 1996 Apr; 41(4):267-9. PubMed ID: 8728081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
